Home » Newsletters » BioWorld Asia

BioWorld Asia

Sep. 15, 1999

View Archived Issues

GPC, Novalon Enter Alliance To Discover Novel Antibiotics

Gene Inactivation, Not Mutation May Be Cause Of Some Cancers

Micrologix Working On Phase III; Antimicrobial Drug On Fast Track

Gemini, Celera Collaborate In Area Of Age-Related Diseases

IGT Subsidiary To Spin Out After Investment From BIRC

BioIndustry Calls For National Center After Visit To The U.S.

CAT Signs Deal With AstraZeneca, Sees Positive Results In Trial

D-Pharm Taking Epilepsy Drug Into Phase II After First Studies

Evotec Going Public In Germany To Advance Discovery Platforms

Peptide, SmithKline Continue Work Despite Recent Setback

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...